These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 2648678)
21. Adoptive immunotherapy in gastrointestine malignancies using interleukin-2. Current results and future prospects. Marshall GD Acta Chir Scand Suppl; 1989; 549():71-4. PubMed ID: 2784605 [No Abstract] [Full Text] [Related]
22. The suppressor-cell network in cancer (second of two parts). Broder S; Waldmann TA N Engl J Med; 1978 Dec; 299(24):1335-41. PubMed ID: 362202 [No Abstract] [Full Text] [Related]
23. The gordian knot of tumour immunology. Amlot P Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511 [No Abstract] [Full Text] [Related]
24. [Use of interleukin 2-activated lymphocytes (LAK cells) in adoptive immunotherapy of neoplasms]. Robak T Pol Tyg Lek; 1988 Nov; 43(47):1491-5. PubMed ID: 3266975 [No Abstract] [Full Text] [Related]
25. Immunodeficiency and cancer: prospects for correction. Hadden JW Int Immunopharmacol; 2003 Aug; 3(8):1061-71. PubMed ID: 12860163 [TBL] [Abstract][Full Text] [Related]
26. Complement function in mAb-mediated cancer immunotherapy. Gelderman KA; Tomlinson S; Ross GD; Gorter A Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044 [No Abstract] [Full Text] [Related]
27. Cancer immunotherapy by local transfer of autologous T lymphocytes cultured with T cell growth factor and autologous tumor extract: a clinical trial. Kan N; Ohgaki K; Yamasaki N; Hori T; Nakayama N; Nio Y; Inamoto T; Hikasa Y Nihon Geka Hokan; 1983 Nov; 52(6):841-53. PubMed ID: 6380446 [No Abstract] [Full Text] [Related]
35. [Immunologic deficiencies and current trials in immunotherapy]. Schwick HG Verh Dtsch Ges Inn Med; 1987; 93():110-7. PubMed ID: 3442097 [No Abstract] [Full Text] [Related]
36. [Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells]. Osanto S; Brand A; van Rood JJ; Cleton FJ Ned Tijdschr Geneeskd; 1989 Jul; 133(28):1392-5. PubMed ID: 2677758 [No Abstract] [Full Text] [Related]
37. Adoptive immunotherapy of cancer: accomplishments and prospects. Rosenberg SA Cancer Treat Rep; 1984 Jan; 68(1):233-55. PubMed ID: 6362866 [TBL] [Abstract][Full Text] [Related]
38. Development of new immunologic approaches to cancer therapy. Rosenberg SA Blood Purif; 1988; 6(2):69-76. PubMed ID: 3293619 [TBL] [Abstract][Full Text] [Related]
39. [Studies on adoptive immunotherapy using recombinant interleukin 2]. Sugiyama Y; Takao H; Saji S; Sakata K Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1307-13. PubMed ID: 3488028 [TBL] [Abstract][Full Text] [Related]
40. Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells. Hiserodt JC; Vujanovic NL; Reynolds CW; Herberman RB; Cramer DV Prog Clin Biol Res; 1987; 244():137-46. PubMed ID: 2958869 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]